VIVOS THERAPEUTICS, INC. (VVOS) Shareholders’ equity 2019–2025
VIVOS THERAPEUTICS, INC. (VVOS) shareholders’ equity at each fiscal year-end, per SEC filings.
-$1.5MFY2025 · since FY2019: -$2.9M → -$1.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.5M | -118.7% |
| FY2024 | $8.0M | +1835.3% |
| FY2023 | $411,000 | -91.4% |
| FY2022 | $4.8M | -81.2% |
| FY2021 | $25.5M | +51.0% |
| FY2020 | $16.9M | +674.8% |
| FY2019 | -$2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice